electroCore Q4 EPS $(0.34) Beats $(0.41) Estimate, Sales $9.200M Beat $9.039M Estimate
3/19/2026
Impact: 60
Healthcare
electroCore (NASDAQ: ECOR) reported Q4 losses of $(0.34) per share, surpassing the analyst estimate of $(0.41) by 16.46%. This reflects a 15% increase in losses compared to $(0.40) per share from the same period last year. The company achieved quarterly sales of $9.200 million, exceeding the $9.039 million estimate by 1.78%, and marking a 30.57% increase from $7.046 million in the prior year.
AI summary, not financial advice
Share: